| Heading: |
Cancer: Medical Treatments |
| Question ID: |
1824057 |
| UIN: |
68532 |
| House: |
Commons |
| Date tabled: |
2025-07-16 |
| Asking Member ID: |
5218 |
| Asking Member display name: |
David Smith
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
David Smith
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) campaigners and (b) stakeholders on treatment for (i) lobular breast cancer and (ii) other rare cancers. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-08-06 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Improving outcomes and experiences of cancer treatment, including lobular breast cancer and other rare cancers, is a priority for the Government. Engagement with campaigners and partners is vital to achieving this.My rt. Hon. Friend, the Secretary of Stat... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |